Organon & Co | OGN - 自己資本および準備金





自己資本および準備金 変化する 日付
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Celltrion KRW 449.2B 14.38B 2026-06
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.24B 69.4M 2026-09
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Gilead Sciences USD 13.04B 1.3B 2026-09
Glaxosmithkline GBP 18.36B 940M 2026-09
Kangmei Pharma CNY 7.83B 524.96M 2026-06
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Merck USD 44.89B 2.96B 2026-09
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Novartis USD 37.56B 1.36B 2026-09
Organigram Holdings CAD 485.46M 113.65M 2026-06
Organon & Co USD 1.19B 187M 2026-09
Ovoca Bio EUR 780K 485K 2025-12
Pharma Mar EUR 237M 13.77M 2026-09
Qiagen NV USD 3.36B 26.03M 2026-06
Sartorius EUR 2.93B 110.1M 2026-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tilray USD 1.58B 39.08M 2025-09
Zealand Pharma A/S 14.47B 361.61M 2026-03